

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.16755572 |
| 2 | DNA deamination (GO:0045006) | 4.94771685 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 4.73310141 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.73310141 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 4.61904015 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30181929 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30181929 |
| 8 | valine metabolic process (GO:0006573) | 4.25005009 |
| 9 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.11038430 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.03410492 |
| 11 | protein maturation by protein folding (GO:0022417) | 3.99914334 |
| 12 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.98476888 |
| 13 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.94790113 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.92510036 |
| 15 | respiratory electron transport chain (GO:0022904) | 3.87039595 |
| 16 | deoxyribonucleotide catabolic process (GO:0009264) | 3.86384665 |
| 17 | GDP-mannose metabolic process (GO:0019673) | 3.80477090 |
| 18 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.78142596 |
| 19 | electron transport chain (GO:0022900) | 3.77331154 |
| 20 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.75884503 |
| 21 | NADH dehydrogenase complex assembly (GO:0010257) | 3.75884503 |
| 22 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.75884503 |
| 23 | GTP biosynthetic process (GO:0006183) | 3.75692623 |
| 24 | protein targeting to mitochondrion (GO:0006626) | 3.73909290 |
| 25 | protein insertion into membrane (GO:0051205) | 3.72193769 |
| 26 | pentose metabolic process (GO:0019321) | 3.70864500 |
| 27 | chaperone-mediated protein transport (GO:0072321) | 3.66187911 |
| 28 | establishment of protein localization to mitochondrion (GO:0072655) | 3.63670730 |
| 29 | viral transcription (GO:0019083) | 3.61545742 |
| 30 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.60473384 |
| 31 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.60473384 |
| 32 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.58888276 |
| 33 | UTP biosynthetic process (GO:0006228) | 3.57733332 |
| 34 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.57599317 |
| 35 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.54231880 |
| 36 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.54170190 |
| 37 | * protein complex biogenesis (GO:0070271) | 3.50769841 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.49569833 |
| 39 | translational termination (GO:0006415) | 3.48953725 |
| 40 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.47344129 |
| 41 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.47016600 |
| 42 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.43339413 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.43077879 |
| 44 | histone arginine methylation (GO:0034969) | 3.41438818 |
| 45 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.40602002 |
| 46 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.39072595 |
| 47 | CTP biosynthetic process (GO:0006241) | 3.37769160 |
| 48 | CTP metabolic process (GO:0046036) | 3.37769160 |
| 49 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.37631968 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 3.36924030 |
| 51 | oxaloacetate metabolic process (GO:0006107) | 3.35221624 |
| 52 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.34692610 |
| 53 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.34649937 |
| 54 | UTP metabolic process (GO:0046051) | 3.33661215 |
| 55 | deoxyribose phosphate metabolic process (GO:0019692) | 3.33215357 |
| 56 | protein localization to mitochondrion (GO:0070585) | 3.30833871 |
| 57 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.29417407 |
| 58 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.27791782 |
| 59 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.27642155 |
| 60 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.27182288 |
| 61 | negative regulation of B cell apoptotic process (GO:0002903) | 3.27055605 |
| 62 | * mitochondrial respiratory chain complex assembly (GO:0033108) | 3.27052038 |
| 63 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.26905420 |
| 64 | translational elongation (GO:0006414) | 3.26610588 |
| 65 | base-excision repair, AP site formation (GO:0006285) | 3.25553810 |
| 66 | protein targeting to ER (GO:0045047) | 3.23300846 |
| 67 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22904657 |
| 68 | cotranslational protein targeting to membrane (GO:0006613) | 3.21582615 |
| 69 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.16698223 |
| 70 | mitochondrial fusion (GO:0008053) | 3.14885557 |
| 71 | ATP biosynthetic process (GO:0006754) | 3.11863235 |
| 72 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.10790592 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09969049 |
| 74 | protein localization to endoplasmic reticulum (GO:0070972) | 3.09324311 |
| 75 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.06049407 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.01966714 |
| 77 | peptidyl-arginine methylation (GO:0018216) | 3.01693745 |
| 78 | peptidyl-arginine N-methylation (GO:0035246) | 3.01693745 |
| 79 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01669040 |
| 80 | positive regulation of mitochondrial fission (GO:0090141) | 3.01569250 |
| 81 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00909441 |
| 82 | proteasome assembly (GO:0043248) | 2.99985523 |
| 83 | * cellular component biogenesis (GO:0044085) | 2.99474623 |
| 84 | mitochondrial calcium ion transport (GO:0006851) | 2.97761149 |
| 85 | pentose-phosphate shunt (GO:0006098) | 2.97681320 |
| 86 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.94476442 |
| 87 | * metallo-sulfur cluster assembly (GO:0031163) | 2.93613240 |
| 88 | * iron-sulfur cluster assembly (GO:0016226) | 2.93613240 |
| 89 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.93344802 |
| 90 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.91852461 |
| 91 | protein targeting to membrane (GO:0006612) | 2.90226836 |
| 92 | GMP metabolic process (GO:0046037) | 2.89914152 |
| 93 | maturation of SSU-rRNA (GO:0030490) | 2.89764595 |
| 94 | cytochrome complex assembly (GO:0017004) | 2.89658258 |
| 95 | deoxyribonucleotide metabolic process (GO:0009262) | 2.86263994 |
| 96 | response to misfolded protein (GO:0051788) | 2.84928876 |
| 97 | mitochondrial transport (GO:0006839) | 2.82198767 |
| 98 | regulation of mitochondrial translation (GO:0070129) | 2.82127791 |
| 99 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.81454308 |
| 100 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.80006190 |
| 101 | viral life cycle (GO:0019058) | 2.79636210 |
| 102 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.79450164 |
| 103 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.79205805 |
| 104 | branched-chain amino acid metabolic process (GO:0009081) | 2.77317706 |
| 105 | spliceosomal snRNP assembly (GO:0000387) | 2.76589378 |
| 106 | DNA strand elongation (GO:0022616) | 2.75869997 |
| 107 | lysine metabolic process (GO:0006553) | 2.74963962 |
| 108 | lysine catabolic process (GO:0006554) | 2.74963962 |
| 109 | ribosomal small subunit biogenesis (GO:0042274) | 2.74571434 |
| 110 | translational initiation (GO:0006413) | 2.69785776 |
| 111 | COPI coating of Golgi vesicle (GO:0048205) | 2.68743411 |
| 112 | Golgi transport vesicle coating (GO:0048200) | 2.68743411 |
| 113 | regulation of protein heterodimerization activity (GO:0043497) | 2.68701236 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68231211 |
| 115 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.68027717 |
| 116 | oxidative phosphorylation (GO:0006119) | 2.66210783 |
| 117 | folic acid metabolic process (GO:0046655) | 2.65456975 |
| 118 | nucleoside salvage (GO:0043174) | 2.62240471 |
| 119 | cellular protein complex disassembly (GO:0043624) | 2.58702457 |
| 120 | regulation of RIG-I signaling pathway (GO:0039535) | 2.57886041 |
| 121 | purine-containing compound salvage (GO:0043101) | 2.57701960 |
| 122 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.55820716 |
| 123 | IMP biosynthetic process (GO:0006188) | 2.55774511 |
| 124 | Peyers patch development (GO:0048541) | 2.54148843 |
| 125 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.54148843 |
| 126 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.53706118 |
| 127 | NADPH regeneration (GO:0006740) | 2.53705402 |
| 128 | succinate metabolic process (GO:0006105) | 2.51294401 |
| 129 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.49752509 |
| 130 | regulation of response to interferon-gamma (GO:0060330) | 2.46471895 |
| 131 | negative regulation of necroptotic process (GO:0060546) | 2.45517466 |
| 132 | pyrimidine-containing compound salvage (GO:0008655) | 2.44423110 |
| 133 | pyrimidine nucleoside salvage (GO:0043097) | 2.44423110 |
| 134 | proline biosynthetic process (GO:0006561) | 2.43419956 |
| 135 | nucleobase biosynthetic process (GO:0046112) | 2.42193875 |
| 136 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.40149546 |
| 137 | ribosome biogenesis (GO:0042254) | 2.39992865 |
| 138 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.39779724 |
| 139 | ribosomal large subunit biogenesis (GO:0042273) | 2.39750585 |
| 140 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38579153 |
| 141 | tricarboxylic acid cycle (GO:0006099) | 2.37854493 |
| 142 | glycine metabolic process (GO:0006544) | 2.37021420 |
| 143 | translation (GO:0006412) | 2.36825934 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.36501304 |
| 145 | IMP metabolic process (GO:0046040) | 2.36461774 |
| 146 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.34924980 |
| 147 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34363167 |
| 148 | L-phenylalanine metabolic process (GO:0006558) | 2.34363167 |
| 149 | protein complex disassembly (GO:0043241) | 2.33881222 |
| 150 | regulation of respiratory burst (GO:0060263) | 2.33826876 |
| 151 | B cell mediated immunity (GO:0019724) | 2.33553065 |
| 152 | serine family amino acid biosynthetic process (GO:0009070) | 2.29526750 |
| 153 | telomere maintenance via recombination (GO:0000722) | 2.29215694 |
| 154 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.28945924 |
| 155 | pseudouridine synthesis (GO:0001522) | 2.28330704 |
| 156 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.27960012 |
| 157 | positive regulation of B cell differentiation (GO:0045579) | 2.27754907 |
| 158 | myeloid dendritic cell activation (GO:0001773) | 2.27508927 |
| 159 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.27378169 |
| 160 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.27204837 |
| 161 | deoxyribose phosphate catabolic process (GO:0046386) | 2.24856277 |
| 162 | purine nucleobase biosynthetic process (GO:0009113) | 2.24673360 |
| 163 | branched-chain amino acid catabolic process (GO:0009083) | 2.23303265 |
| 164 | pteridine-containing compound metabolic process (GO:0042558) | 2.23228454 |
| 165 | macromolecular complex disassembly (GO:0032984) | 2.22480979 |
| 166 | nucleotide salvage (GO:0043173) | 2.22046363 |
| 167 | natural killer cell differentiation (GO:0001779) | 2.21985090 |
| 168 | formation of translation preinitiation complex (GO:0001731) | 2.21972222 |
| 169 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.21428372 |
| 170 | regulation of necroptotic process (GO:0060544) | 2.21215043 |
| 171 | tetrahydrofolate metabolic process (GO:0046653) | 2.20328631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.36455321 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.93317647 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.72904186 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.93388318 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53369449 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44647164 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.44447920 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.34863702 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.32946207 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32292349 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27337853 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.22161466 |
| 13 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20641098 |
| 14 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.09555228 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07219462 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06889839 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.03580126 |
| 18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.00033627 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.99784326 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.95660886 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95392895 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.95376448 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.84160396 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.83246702 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.82054803 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.80829586 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.79247985 |
| 28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.78881457 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78842136 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78378392 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.77065365 |
| 32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76278845 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75862099 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.75775419 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75081875 |
| 36 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73758717 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71559039 |
| 38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.71358746 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70914623 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69382925 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68754297 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67975193 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.65734437 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64862707 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64810801 |
| 46 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63693372 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63534651 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62926487 |
| 49 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62905570 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59609314 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58359041 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57500973 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56108357 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.55514453 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.50013339 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49033241 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48824100 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48625172 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46301499 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46171268 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44589352 |
| 62 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44171436 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43726086 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42097285 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41147324 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40723495 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.40211202 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39365526 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39326027 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.39281232 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39184349 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38608224 |
| 73 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.37889852 |
| 74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37370841 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.36841921 |
| 76 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.36759738 |
| 77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.36536081 |
| 78 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36107623 |
| 79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35282117 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34514515 |
| 81 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33600187 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32408878 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31064655 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29059812 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28897284 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27828718 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27270361 |
| 88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27227118 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27191222 |
| 90 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25740729 |
| 91 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.25148864 |
| 92 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22850697 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21411725 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 1.21038755 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.20626306 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20233083 |
| 97 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20150318 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19774278 |
| 99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18497850 |
| 100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18442197 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17591241 |
| 102 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17382250 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17052663 |
| 104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16941537 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16750958 |
| 106 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15907966 |
| 107 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.15480397 |
| 108 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14327865 |
| 109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13766576 |
| 110 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13235640 |
| 111 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.12890356 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12750273 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10904402 |
| 114 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08653947 |
| 115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07937437 |
| 116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07870877 |
| 117 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07766824 |
| 118 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07377280 |
| 119 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07272014 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07152375 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07122881 |
| 122 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07059770 |
| 123 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06459374 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06326447 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06258691 |
| 126 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06003416 |
| 127 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04640561 |
| 128 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04589001 |
| 129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04134446 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04121652 |
| 131 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03995087 |
| 132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03776316 |
| 133 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03134711 |
| 134 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02850068 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01636067 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01610575 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01610364 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01352113 |
| 139 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00779986 |
| 140 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00763078 |
| 141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99607425 |
| 142 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98052320 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97652230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 3.73147354 |
| 2 | MP0008260_abnormal_autophagy | 3.43264266 |
| 3 | MP0000685_abnormal_immune_system | 2.97053326 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.96511262 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.78837358 |
| 6 | MP0006035_abnormal_mitochondrial_morpho | 2.65843217 |
| 7 | MP0009840_abnormal_foam_cell | 2.40875750 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.39966731 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.35420245 |
| 10 | MP0005360_urolithiasis | 2.29793441 |
| 11 | MP0002822_catalepsy | 2.16923038 |
| 12 | MP0000678_abnormal_parathyroid_gland | 2.16512759 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.13579767 |
| 14 | MP0005451_abnormal_body_composition | 2.07663241 |
| 15 | MP0009278_abnormal_bone_marrow | 2.07561343 |
| 16 | MP0005671_abnormal_response_to | 2.07327649 |
| 17 | MP0003786_premature_aging | 2.07136004 |
| 18 | MP0008932_abnormal_embryonic_tissue | 2.06444756 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.05536314 |
| 20 | MP0002653_abnormal_ependyma_morphology | 1.98232441 |
| 21 | MP0008995_early_reproductive_senescence | 1.97046502 |
| 22 | MP0005365_abnormal_bile_salt | 1.95839389 |
| 23 | MP0001873_stomach_inflammation | 1.95139612 |
| 24 | MP0001800_abnormal_humoral_immune | 1.90870299 |
| 25 | MP0000490_abnormal_crypts_of | 1.83514677 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.81340332 |
| 27 | MP0009785_altered_susceptibility_to | 1.81134237 |
| 28 | MP0003693_abnormal_embryo_hatching | 1.78296213 |
| 29 | MP0001853_heart_inflammation | 1.76330521 |
| 30 | MP0009379_abnormal_foot_pigmentation | 1.70864921 |
| 31 | MP0002254_reproductive_system_inflammat | 1.70823562 |
| 32 | MP0002398_abnormal_bone_marrow | 1.69675008 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.67632096 |
| 34 | MP0005387_immune_system_phenotype | 1.65855792 |
| 35 | MP0001790_abnormal_immune_system | 1.65855792 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.64111978 |
| 37 | MP0005025_abnormal_response_to | 1.63714192 |
| 38 | MP0002723_abnormal_immune_serum | 1.62182437 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.62139684 |
| 40 | MP0003436_decreased_susceptibility_to | 1.61140272 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.60896164 |
| 42 | MP0001819_abnormal_immune_cell | 1.58956134 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.58856200 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.58321649 |
| 45 | MP0003186_abnormal_redox_activity | 1.58129027 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.57830965 |
| 47 | MP0001346_abnormal_lacrimal_gland | 1.56346300 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.54473552 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.52567947 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.51328723 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.51059421 |
| 52 | MP0001905_abnormal_dopamine_level | 1.48404054 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.47422259 |
| 54 | MP0002722_abnormal_immune_system | 1.47107037 |
| 55 | MP0000716_abnormal_immune_system | 1.46228587 |
| 56 | MP0001727_abnormal_embryo_implantation | 1.45602089 |
| 57 | MP0010094_abnormal_chromosome_stability | 1.41609549 |
| 58 | MP0002429_abnormal_blood_cell | 1.41480961 |
| 59 | MP0001529_abnormal_vocalization | 1.40794564 |
| 60 | MP0000358_abnormal_cell_content/ | 1.40656643 |
| 61 | MP0003724_increased_susceptibility_to | 1.40200916 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.37723958 |
| 63 | MP0003077_abnormal_cell_cycle | 1.36290735 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.35921799 |
| 65 | MP0008007_abnormal_cellular_replicative | 1.34942495 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.33847175 |
| 67 | MP0003303_peritoneal_inflammation | 1.32706562 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.32128760 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.31792646 |
| 70 | MP0002405_respiratory_system_inflammati | 1.31655442 |
| 71 | MP0008469_abnormal_protein_level | 1.30088959 |
| 72 | MP0000681_abnormal_thyroid_gland | 1.28281886 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.26930250 |
| 74 | MP0000609_abnormal_liver_physiology | 1.26629864 |
| 75 | MP0008058_abnormal_DNA_repair | 1.26545476 |
| 76 | MP0006054_spinal_hemorrhage | 1.25678329 |
| 77 | MP0004957_abnormal_blastocyst_morpholog | 1.24165094 |
| 78 | MP0003866_abnormal_defecation | 1.24044268 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.23998486 |
| 80 | MP0005394_taste/olfaction_phenotype | 1.22199673 |
| 81 | MP0005499_abnormal_olfactory_system | 1.22199673 |
| 82 | MP0004510_myositis | 1.21095830 |
| 83 | MP0005501_abnormal_skin_physiology | 1.20450773 |
| 84 | MP0000372_irregular_coat_pigmentation | 1.20141840 |
| 85 | MP0005332_abnormal_amino_acid | 1.19512438 |
| 86 | MP0002735_abnormal_chemical_nociception | 1.19262252 |
| 87 | MP0002419_abnormal_innate_immunity | 1.19053834 |
| 88 | MP0008874_decreased_physiological_sensi | 1.18327368 |
| 89 | MP0001661_extended_life_span | 1.17627150 |
| 90 | MP0003111_abnormal_nucleus_morphology | 1.16007614 |
| 91 | MP0000750_abnormal_muscle_regeneration | 1.15926060 |
| 92 | MP0001764_abnormal_homeostasis | 1.15711376 |
| 93 | MP0002163_abnormal_gland_morphology | 1.15467667 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12096635 |
| 95 | MP0002132_abnormal_respiratory_system | 1.10441404 |
| 96 | MP0001545_abnormal_hematopoietic_system | 1.10282729 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 1.10282729 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 1.09389564 |
| 99 | MP0002019_abnormal_tumor_incidence | 1.08920009 |
| 100 | MP0002249_abnormal_larynx_morphology | 1.08052441 |
| 101 | MP0005464_abnormal_platelet_physiology | 1.07949202 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 1.07078738 |
| 103 | MP0002006_tumorigenesis | 1.06934948 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 1.05751563 |
| 105 | MP0003123_paternal_imprinting | 1.05324072 |
| 106 | MP0003646_muscle_fatigue | 1.04303948 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03713922 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 1.03025699 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 1.02399114 |
| 110 | MP0000598_abnormal_liver_morphology | 1.00543838 |
| 111 | MP0004147_increased_porphyrin_level | 1.00444937 |
| 112 | MP0003252_abnormal_bile_duct | 0.99827968 |
| 113 | MP0001348_abnormal_lacrimal_gland | 0.98342965 |
| 114 | MP0003315_abnormal_perineum_morphology | 0.97725430 |
| 115 | MP0000858_altered_metastatic_potential | 0.96916647 |
| 116 | MP0004947_skin_inflammation | 0.96388281 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.94521275 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.93080102 |
| 119 | MP0009764_decreased_sensitivity_to | 0.93004130 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.91541945 |
| 121 | MP0000371_diluted_coat_color | 0.89611933 |
| 122 | MP0005670_abnormal_white_adipose | 0.88643705 |
| 123 | MP0005310_abnormal_salivary_gland | 0.88623685 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.88217460 |
| 125 | MP0000049_abnormal_middle_ear | 0.87147737 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86213145 |
| 127 | MP0000343_altered_response_to | 0.85993517 |
| 128 | MP0003011_delayed_dark_adaptation | 0.84659493 |
| 129 | MP0000313_abnormal_cell_death | 0.84266530 |
| 130 | MP0006292_abnormal_olfactory_placode | 0.83027624 |
| 131 | MP0008057_abnormal_DNA_replication | 0.81963115 |
| 132 | MP0001666_abnormal_nutrient_absorption | 0.81626675 |
| 133 | MP0001968_abnormal_touch/_nociception | 0.81081155 |
| 134 | MP0005083_abnormal_biliary_tract | 0.79899157 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.79199816 |
| 136 | MP0003075_altered_response_to | 0.78445865 |
| 137 | MP0003195_calcinosis | 0.78418605 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.77803533 |
| 139 | MP0002970_abnormal_white_adipose | 0.77618940 |
| 140 | MP0005166_decreased_susceptibility_to | 0.77062901 |
| 141 | MP0009763_increased_sensitivity_to | 0.77043774 |
| 142 | MP0003943_abnormal_hepatobiliary_system | 0.76600262 |
| 143 | MP0008873_increased_physiological_sensi | 0.75344161 |
| 144 | MP0005330_cardiomyopathy | 0.75115023 |
| 145 | MP0004742_abnormal_vestibular_system | 0.73203065 |
| 146 | MP0005266_abnormal_metabolism | 0.67981915 |
| 147 | MP0002733_abnormal_thermal_nociception | 0.67944494 |
| 148 | MP0002736_abnormal_nociception_after | 0.67327032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Microvesicular hepatic steatosis (HP:0001414) | 4.54309975 |
| 2 | Renal Fanconi syndrome (HP:0001994) | 4.01733739 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.92877811 |
| 4 | * Abnormal mitochondria in muscle tissue (HP:0008316) | 3.92473295 |
| 5 | * Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.82174032 |
| 6 | * Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.82174032 |
| 7 | IgM deficiency (HP:0002850) | 3.59544958 |
| 8 | Acute encephalopathy (HP:0006846) | 3.50672262 |
| 9 | Congenital stationary night blindness (HP:0007642) | 3.41440395 |
| 10 | Hepatic necrosis (HP:0002605) | 3.38065106 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.28608058 |
| 12 | Thrombocytosis (HP:0001894) | 3.17727731 |
| 13 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.07845963 |
| 14 | Hypoglycemic coma (HP:0001325) | 3.06175664 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.02752117 |
| 16 | Reticulocytopenia (HP:0001896) | 2.99389778 |
| 17 | Increased serum pyruvate (HP:0003542) | 2.96426894 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96096877 |
| 19 | Hypertensive crisis (HP:0100735) | 2.96025774 |
| 20 | Abnormality of glycolysis (HP:0004366) | 2.94020616 |
| 21 | Progressive macrocephaly (HP:0004481) | 2.93769965 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.92116407 |
| 23 | Generalized aminoaciduria (HP:0002909) | 2.88520511 |
| 24 | Prolonged neonatal jaundice (HP:0006579) | 2.86705534 |
| 25 | Truncus arteriosus (HP:0001660) | 2.85729233 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82652369 |
| 27 | * Exercise intolerance (HP:0003546) | 2.78487599 |
| 28 | Abnormal number of erythroid precursors (HP:0012131) | 2.76541923 |
| 29 | Multiple enchondromatosis (HP:0005701) | 2.71207588 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 2.69824790 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69678343 |
| 32 | Aplastic anemia (HP:0001915) | 2.69119511 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66085849 |
| 34 | Obstructive lung disease (HP:0006536) | 2.62538889 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62538889 |
| 36 | Abnormality of reticulocytes (HP:0004312) | 2.59906743 |
| 37 | Emotional lability (HP:0000712) | 2.58203942 |
| 38 | Oral leukoplakia (HP:0002745) | 2.56982627 |
| 39 | Hyperammonemia (HP:0001987) | 2.55130446 |
| 40 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.51513158 |
| 41 | Respiratory failure (HP:0002878) | 2.51462095 |
| 42 | Myopathic facies (HP:0002058) | 2.50903115 |
| 43 | Rhabdomyolysis (HP:0003201) | 2.50529013 |
| 44 | Ketosis (HP:0001946) | 2.49501972 |
| 45 | * Increased muscle lipid content (HP:0009058) | 2.48608036 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.47987698 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47987698 |
| 48 | Late onset (HP:0003584) | 2.44342111 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.44168484 |
| 50 | Cholecystitis (HP:0001082) | 2.44168484 |
| 51 | Ketoacidosis (HP:0001993) | 2.43697076 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.40976856 |
| 53 | Macrocytic anemia (HP:0001972) | 2.39774276 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39075908 |
| 55 | Abnormality of T cells (HP:0002843) | 2.36023023 |
| 56 | Myoglobinuria (HP:0002913) | 2.35616288 |
| 57 | Myositis (HP:0100614) | 2.34021896 |
| 58 | Nasal polyposis (HP:0100582) | 2.32848800 |
| 59 | Muscle fiber atrophy (HP:0100295) | 2.32821136 |
| 60 | Hyperthyroidism (HP:0000836) | 2.32162754 |
| 61 | * Increased serum lactate (HP:0002151) | 2.32052212 |
| 62 | Chronic otitis media (HP:0000389) | 2.31848869 |
| 63 | * Increased intramyocellular lipid droplets (HP:0012240) | 2.31610163 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.31227340 |
| 65 | Progressive muscle weakness (HP:0003323) | 2.30678300 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29014958 |
| 67 | Respiratory difficulties (HP:0002880) | 2.23187310 |
| 68 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.22658170 |
| 69 | * Lactic acidosis (HP:0003128) | 2.22284371 |
| 70 | Gout (HP:0001997) | 2.21511381 |
| 71 | Broad distal phalanx of finger (HP:0009836) | 2.19360973 |
| 72 | Type 2 muscle fiber atrophy (HP:0003554) | 2.16294239 |
| 73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.13387555 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.13130108 |
| 75 | Type I transferrin isoform profile (HP:0003642) | 2.12552489 |
| 76 | Rough bone trabeculation (HP:0100670) | 2.12416596 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.12393225 |
| 78 | Hyperalaninemia (HP:0003348) | 2.12393225 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.12393225 |
| 80 | Progressive microcephaly (HP:0000253) | 2.10348658 |
| 81 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09951012 |
| 82 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09951012 |
| 83 | Abnormal protein glycosylation (HP:0012346) | 2.09951012 |
| 84 | Abnormal glycosylation (HP:0012345) | 2.09951012 |
| 85 | Metabolic acidosis (HP:0001942) | 2.07309910 |
| 86 | Exertional dyspnea (HP:0002875) | 2.06614162 |
| 87 | Pustule (HP:0200039) | 2.06451539 |
| 88 | Myokymia (HP:0002411) | 2.05182182 |
| 89 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04829017 |
| 90 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04810049 |
| 91 | Growth hormone excess (HP:0000845) | 2.03904950 |
| 92 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02603444 |
| 93 | Pallor (HP:0000980) | 2.02186963 |
| 94 | Abnormality of the nasal mucosa (HP:0000433) | 2.02063295 |
| 95 | Visual hallucinations (HP:0002367) | 2.01197133 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01139556 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01139556 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01139556 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.00791422 |
| 100 | Increased CSF lactate (HP:0002490) | 2.00666595 |
| 101 | Cerebral palsy (HP:0100021) | 2.00433809 |
| 102 | Mitochondrial inheritance (HP:0001427) | 1.98616650 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 1.97248048 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 1.97211389 |
| 105 | Microretrognathia (HP:0000308) | 1.95561160 |
| 106 | Failure to thrive in infancy (HP:0001531) | 1.95509498 |
| 107 | Increased serum ferritin (HP:0003281) | 1.95307035 |
| 108 | Abnormality of renal resorption (HP:0011038) | 1.95164738 |
| 109 | Reticulocytosis (HP:0001923) | 1.93618492 |
| 110 | Eczematoid dermatitis (HP:0000976) | 1.93357558 |
| 111 | Hyperbilirubinemia (HP:0002904) | 1.93181215 |
| 112 | Fatigue (HP:0012378) | 1.92728251 |
| 113 | Proximal tubulopathy (HP:0000114) | 1.91590704 |
| 114 | Double outlet right ventricle (HP:0001719) | 1.91484086 |
| 115 | Congenital malformation of the right heart (HP:0011723) | 1.91484086 |
| 116 | Petechiae (HP:0000967) | 1.91442463 |
| 117 | Abnormality of DNA repair (HP:0003254) | 1.91311747 |
| 118 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91116544 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.90367683 |
| 120 | Acute hepatic failure (HP:0006554) | 1.89529894 |
| 121 | Inflammation of the large intestine (HP:0002037) | 1.88988247 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.88110559 |
| 123 | Recurrent viral infections (HP:0004429) | 1.87680486 |
| 124 | Hypergonadotropic hypogonadism (HP:0000815) | 1.87479526 |
| 125 | Seborrheic dermatitis (HP:0001051) | 1.86951086 |
| 126 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.86561341 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86233298 |
| 128 | Gastrointestinal stroma tumor (HP:0100723) | 1.85816499 |
| 129 | * Ragged-red muscle fibers (HP:0003200) | 1.85731089 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 1.85082511 |
| 131 | Glycosuria (HP:0003076) | 1.85082511 |
| 132 | Bulbar palsy (HP:0001283) | 1.83178682 |
| 133 | Delusions (HP:0000746) | 1.82859256 |
| 134 | Pancytopenia (HP:0001876) | 1.82792477 |
| 135 | Abnormality of the parathyroid morphology (HP:0011766) | 1.82239976 |
| 136 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81743623 |
| 137 | Hypoparathyroidism (HP:0000829) | 1.81404846 |
| 138 | Impaired platelet aggregation (HP:0003540) | 1.81222140 |
| 139 | Abnormal platelet function (HP:0011869) | 1.81222140 |
| 140 | Gliosis (HP:0002171) | 1.81018816 |
| 141 | Fasciculations (HP:0002380) | 1.80104165 |
| 142 | Recurrent bacterial skin infections (HP:0005406) | 1.79737412 |
| 143 | Cerebral hypomyelination (HP:0006808) | 1.79726467 |
| 144 | Hyperphosphaturia (HP:0003109) | 1.79614078 |
| 145 | Delayed CNS myelination (HP:0002188) | 1.78314477 |
| 146 | Hepatosplenomegaly (HP:0001433) | 1.78174245 |
| 147 | Increased purine levels (HP:0004368) | 1.77951922 |
| 148 | Hyperuricemia (HP:0002149) | 1.77951922 |
| 149 | Lymphopenia (HP:0001888) | 1.77697489 |
| 150 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77378214 |
| 151 | Palpitations (HP:0001962) | 1.77329392 |
| 152 | Retinal dysplasia (HP:0007973) | 1.75319820 |
| 153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74919617 |
| 154 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74906725 |
| 155 | Recurrent abscess formation (HP:0002722) | 1.73994252 |
| 156 | Lethargy (HP:0001254) | 1.73102494 |
| 157 | Cerebral edema (HP:0002181) | 1.72747175 |
| 158 | Hyperglycinuria (HP:0003108) | 1.72582792 |
| 159 | Chronic diarrhea (HP:0002028) | 1.72100142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.90387143 |
| 2 | NME2 | 3.27697696 |
| 3 | BCKDK | 3.24526511 |
| 4 | ARAF | 2.92777726 |
| 5 | EIF2AK1 | 2.90260933 |
| 6 | FLT3 | 2.85545769 |
| 7 | MAP4K1 | 2.55871454 |
| 8 | JAK3 | 2.53995188 |
| 9 | TRIB3 | 2.44771932 |
| 10 | ERN1 | 2.39394468 |
| 11 | SCYL2 | 2.29469395 |
| 12 | TYK2 | 2.01684472 |
| 13 | RPS6KA4 | 1.97999541 |
| 14 | ZAP70 | 1.89699447 |
| 15 | TBK1 | 1.86771717 |
| 16 | TESK2 | 1.85056452 |
| 17 | TLK1 | 1.83676616 |
| 18 | SMG1 | 1.82227585 |
| 19 | PKN2 | 1.81618094 |
| 20 | FGFR4 | 1.78027818 |
| 21 | KDR | 1.73992939 |
| 22 | DYRK3 | 1.69970324 |
| 23 | DAPK1 | 1.69888530 |
| 24 | MAP3K11 | 1.59942938 |
| 25 | ACVR1B | 1.59675581 |
| 26 | TXK | 1.59079807 |
| 27 | IKBKB | 1.57442580 |
| 28 | BTK | 1.55210986 |
| 29 | PASK | 1.53579444 |
| 30 | MAPKAPK3 | 1.51948103 |
| 31 | MAP3K10 | 1.42965105 |
| 32 | CSNK1G3 | 1.39784107 |
| 33 | BLK | 1.38581549 |
| 34 | MAP3K14 | 1.36958900 |
| 35 | LIMK1 | 1.36398105 |
| 36 | STK16 | 1.36301598 |
| 37 | MAP2K3 | 1.35494655 |
| 38 | IRAK4 | 1.34805903 |
| 39 | BUB1 | 1.33330233 |
| 40 | IKBKE | 1.31325166 |
| 41 | NEK9 | 1.28607592 |
| 42 | LRRK2 | 1.26990770 |
| 43 | PIM2 | 1.26137094 |
| 44 | ABL2 | 1.25801872 |
| 45 | KIT | 1.24486506 |
| 46 | CCNB1 | 1.22495825 |
| 47 | TEC | 1.20981432 |
| 48 | TGFBR1 | 1.19831199 |
| 49 | STK10 | 1.18251452 |
| 50 | NME1 | 1.16221902 |
| 51 | MAP2K7 | 1.15483966 |
| 52 | CHUK | 1.14999080 |
| 53 | VRK1 | 1.14135833 |
| 54 | BRAF | 1.09073179 |
| 55 | CSNK1A1L | 1.07948805 |
| 56 | CDK19 | 1.06774527 |
| 57 | EIF2AK3 | 1.05940251 |
| 58 | PIM1 | 1.04292684 |
| 59 | MUSK | 1.03471733 |
| 60 | CSNK1G2 | 1.00633761 |
| 61 | DAPK3 | 0.97932139 |
| 62 | MAP2K6 | 0.97787786 |
| 63 | NEK2 | 0.97201406 |
| 64 | TAOK2 | 0.95276019 |
| 65 | SYK | 0.94789535 |
| 66 | DYRK2 | 0.94005078 |
| 67 | SIK2 | 0.92855985 |
| 68 | WEE1 | 0.89126216 |
| 69 | TESK1 | 0.89034693 |
| 70 | CSF1R | 0.87077149 |
| 71 | MAP3K8 | 0.86525526 |
| 72 | TSSK6 | 0.83892651 |
| 73 | GRK6 | 0.83850417 |
| 74 | IRAK3 | 0.83051821 |
| 75 | MAP3K5 | 0.81160265 |
| 76 | PRPF4B | 0.79774185 |
| 77 | RPS6KB2 | 0.79572160 |
| 78 | IRAK1 | 0.77153758 |
| 79 | CHEK2 | 0.76979528 |
| 80 | MAPK11 | 0.76135060 |
| 81 | INSRR | 0.75754793 |
| 82 | ZAK | 0.75155837 |
| 83 | SRPK1 | 0.74969998 |
| 84 | NLK | 0.74607858 |
| 85 | JAK1 | 0.74586867 |
| 86 | EEF2K | 0.74336227 |
| 87 | MAP4K2 | 0.74151351 |
| 88 | CSNK1G1 | 0.73583931 |
| 89 | ITK | 0.73368434 |
| 90 | PAK4 | 0.73199204 |
| 91 | NEK1 | 0.71519455 |
| 92 | CDK4 | 0.70664863 |
| 93 | HIPK2 | 0.70034818 |
| 94 | MAP3K1 | 0.68927356 |
| 95 | ICK | 0.66762384 |
| 96 | JAK2 | 0.66063347 |
| 97 | PTK6 | 0.65678729 |
| 98 | ILK | 0.63971168 |
| 99 | CDK11A | 0.63786170 |
| 100 | RAF1 | 0.62417852 |
| 101 | MAPK15 | 0.62210335 |
| 102 | PAK1 | 0.59531899 |
| 103 | TIE1 | 0.59045082 |
| 104 | DYRK1B | 0.58860011 |
| 105 | CDK14 | 0.58518037 |
| 106 | PRKG2 | 0.58163563 |
| 107 | LCK | 0.57938710 |
| 108 | BRSK2 | 0.57639315 |
| 109 | LMTK2 | 0.57424434 |
| 110 | CDK7 | 0.56469679 |
| 111 | ATR | 0.56228284 |
| 112 | CDK15 | 0.55884876 |
| 113 | BMPR2 | 0.55587106 |
| 114 | STK4 | 0.55471434 |
| 115 | CAMK2G | 0.54530623 |
| 116 | PRKD3 | 0.53366116 |
| 117 | AURKB | 0.52199514 |
| 118 | AKT2 | 0.50850388 |
| 119 | MAP3K12 | 0.50669829 |
| 120 | PRKCI | 0.50506458 |
| 121 | RPS6KL1 | 0.50434649 |
| 122 | RPS6KC1 | 0.50434649 |
| 123 | CSNK2A2 | 0.50394490 |
| 124 | CDK18 | 0.49800027 |
| 125 | MATK | 0.49418742 |
| 126 | LYN | 0.49327211 |
| 127 | CSNK2A1 | 0.48382042 |
| 128 | MST1R | 0.47641104 |
| 129 | SIK3 | 0.46952606 |
| 130 | MARK3 | 0.46886489 |
| 131 | RPS6KA5 | 0.45241992 |
| 132 | EPHB2 | 0.44069844 |
| 133 | TAF1 | 0.42417528 |
| 134 | GRK7 | 0.41298794 |
| 135 | CDC7 | 0.41106384 |
| 136 | AURKA | 0.40968760 |
| 137 | TTN | 0.40623548 |
| 138 | PLK1 | 0.39872468 |
| 139 | MAPK4 | 0.39675221 |
| 140 | MAP2K2 | 0.37940361 |
| 141 | RPS6KA6 | 0.37662790 |
| 142 | CAMK2B | 0.37540638 |
| 143 | MAPKAPK2 | 0.36453945 |
| 144 | MAP2K4 | 0.35812433 |
| 145 | MAP3K3 | 0.35141072 |
| 146 | GRK5 | 0.34247151 |
| 147 | RPS6KA2 | 0.33950529 |
| 148 | CDK8 | 0.33813392 |
| 149 | IRAK2 | 0.33437158 |
| 150 | RPS6KA1 | 0.32882394 |
| 151 | BRSK1 | 0.32690743 |
| 152 | MAPK12 | 0.32111040 |
| 153 | CSK | 0.30863214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.16923947 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.93299265 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.68594062 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49768144 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.35337757 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.10311647 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.06849355 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.03717874 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.97455885 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90497797 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90237284 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.89337098 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.88103850 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79159124 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.76922628 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75960604 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.72663236 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71984996 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61188073 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59514350 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57948216 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.54054179 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.52232606 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.46473835 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.43976293 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.43398466 |
| 27 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.41406532 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.40416232 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37262307 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36919108 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.35657696 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34330488 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33196023 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30063124 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.29658049 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29228578 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23764418 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19276337 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17633393 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13051753 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12181069 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12126631 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10554596 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09404634 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08054457 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06006613 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04691299 |
| 48 | Measles_Homo sapiens_hsa05162 | 1.04585336 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04546581 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03257032 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02996288 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01759096 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00042933 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97528526 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96570097 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94500732 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94194485 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92771413 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91769922 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91190625 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90978746 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.90022168 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88677264 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88642355 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86147444 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85916947 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84572696 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82273011 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82100930 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81250537 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79380546 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.79207651 |
| 73 | Alcoholism_Homo sapiens_hsa05034 | 0.79126441 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78065796 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77757717 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.77633650 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74653769 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.74542996 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74176971 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73822055 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72157138 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71516312 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.70811303 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69285013 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66661776 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.66478199 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66088188 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.63597965 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63293393 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63219626 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63145069 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61409489 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59489248 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58939134 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58459270 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56608158 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.55120569 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53393090 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53149017 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52711486 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.50505229 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50356826 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49755317 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48567572 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.48480473 |
| 106 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47651883 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.47582609 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47397369 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47226778 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45408992 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44499706 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43310094 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43187784 |
| 114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43049835 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.42268136 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41540822 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.40526515 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38747531 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38724939 |
| 120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37567610 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37284374 |
| 122 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34496257 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34271709 |
| 124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.33321947 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.31325385 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.30827201 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.30235817 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28810812 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23809459 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22701064 |
| 131 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.21656773 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21617402 |

